Information Provided By:
Fly News Breaks for August 14, 2019
THC
Aug 14, 2019 | 06:46 EDT
Goldman Sachs analyst Stephen Tanal reinstated coverage of Tenet Healthcare with a Neutral rating and $28 price target following the conclusion of its strategic review for Conifer. The analyst believes the risk/reward for Tenet's shares look favorable ahead of the proposed Conifer spin, but he looks for signs of sustainability in improved Q2 hospital volumes and better flow-through to earnings growth.
News For THC From the Last 2 Days
There are no results for your query THC